NEB announces issuance of US patent for RNA-seq technology

New England Biolabs, Inc. (NEB®) announces the issuance of United States Patent Number 8,999,677, which describes a novel method for retaining valuable strand-specific information contained within RNA transcripts. The method, which involves the second strand being selectively removed through the excision of UTP molecules, is proving to be particularly useful for RNA-seq applications.

The '677 patent is the first issuance in a family of applications licensed exclusively to NEB from Max Planck Gesellschaft in 2012. NEB has already introduced this technology to the market in products, such as its NEBNext® Ultra™ Directional RNA Library Prep Kit. NEB has also sublicensed this technology to Illumina®, Inc.

NEBNext products are a series of highly pure and cost-effective reagents that facilitate DNA and RNA library preparation for next generation sequencing. The innovative NEBNext product line includes the Ultra Library Prep kits for DNA and RNA, which address the increasing need for fast and robust performance, and also allow the use of low-nanogram amounts of input DNA or RNA – ensuring optimal data quality with flexible workflows.

Source:

New England Biolabs

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    New England Biolabs. (2019, June 19). NEB announces issuance of US patent for RNA-seq technology. News-Medical. Retrieved on August 14, 2022 from https://www.news-medical.net/news/20150506/NEB-announces-issuance-of-US-patent-for-RNA-seq-technology.aspx.

  • MLA

    New England Biolabs. "NEB announces issuance of US patent for RNA-seq technology". News-Medical. 14 August 2022. <https://www.news-medical.net/news/20150506/NEB-announces-issuance-of-US-patent-for-RNA-seq-technology.aspx>.

  • Chicago

    New England Biolabs. "NEB announces issuance of US patent for RNA-seq technology". News-Medical. https://www.news-medical.net/news/20150506/NEB-announces-issuance-of-US-patent-for-RNA-seq-technology.aspx. (accessed August 14, 2022).

  • Harvard

    New England Biolabs. 2019. NEB announces issuance of US patent for RNA-seq technology. News-Medical, viewed 14 August 2022, https://www.news-medical.net/news/20150506/NEB-announces-issuance-of-US-patent-for-RNA-seq-technology.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting